Predicting drug metabolism: A site of metabolism prediction tool applied to the cytochrome P4502C9

被引:123
作者
Zamora, I
Afzelius, L
Cruciani, G
机构
[1] AstraZeneca R&D Molndal, Drug Metab Pharmacokinet & Bioanalyt Chem, Molndal, Sweden
[2] Univ Perugia, Chemometr Grp, I-06100 Perugia, Italy
关键词
D O I
10.1021/jm021104i
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The aim of the present study is to develop a method for predicting the site at which molecules will be metabolized by CYP 2C9 (cytochrome P450 2C9) using a previously reported protein homology model of the enzyme. Such a method would be of great help in designing new compounds with a better pharmacokinetic profile, or in designing prodrugs where the compound needs to be metabolized in order to become active. The methodology is based on a comparison between alignment-independent descriptors derived from GRID Molecular Interaction Fields for the CYP 2C9 active site, and a distance-based representation of the substrate. The predicted site of metabolism is reported as a ranking list of all the hydrogen atoms of each substrate molecule. Eighty-seven CYP 2C9-catalyzed oxidative reactions reported in the literature have been analyzed. In more than 90% of these cases, the hydrogen atom ranked at the first, second, or third position was the experimentally reported site of oxidation.
引用
收藏
页码:2313 / 2324
页数:12
相关论文
共 73 条
[1]   Competitive CYP2C9 inhibitors:: Enzyme inhibition studies, protein homology modeling, and three-dimensional quantitative structure-activity relationship analysis [J].
Afzelius, L ;
Zamora, I ;
Ridderström, M ;
Andersson, TB ;
Karlén, A ;
Masimirembwa, CM .
MOLECULAR PHARMACOLOGY, 2001, 59 (04) :909-919
[2]  
Amat L, 1999, J COMPUT CHEM, V20, P911, DOI 10.1002/(SICI)1096-987X(19990715)20:9<911::AID-JCC2>3.0.CO
[3]  
2-O
[4]  
BLANCK C, 1993, Patent No. 5436265
[5]   Hepatic metabolism of diclofenac:: Role of human CYP in the minor oxidative pathways [J].
Bort, R ;
Macé, K ;
Boobis, A ;
Gómez-Lechón, MJ ;
Pfeifer, A ;
Castell, J .
BIOCHEMICAL PHARMACOLOGY, 1999, 58 (05) :787-796
[6]  
Bort R, 1996, DRUG METAB DISPOS, V24, P834
[7]  
Bourrié M, 1999, DRUG METAB DISPOS, V27, P288
[8]  
BROWN MF, 1997, Patent No. 971751
[9]  
Caraco Y, 2000, CLIN PHARMACOL THER, V67, P98
[10]  
Chiba M, 1997, DRUG METAB DISPOS, V25, P1022